Moleculin kicks off phase 1b/2 annamycin cancer trial
25 May 2021 - 11:14PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
From Apr 2024 to May 2024
Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
From May 2023 to May 2024